Canada markets close in 5 hours 29 minutes

Sangamo Therapeutics, Inc. (SGMO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.6172+0.0198 (+3.31%)
As of 10:31AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 123.97M
Enterprise Value 100.37M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)5.65
Price/Book (mrq)2.19
Enterprise Value/Revenue 5.35
Enterprise Value/EBITDA -1.00

Trading Information

Stock Price History

Beta (5Y Monthly) 1.40
52-Week Change 3-58.04%
S&P500 52-Week Change 329.31%
52 Week High 31.6700
52 Week Low 30.2900
50-Day Moving Average 30.6030
200-Day Moving Average 30.6450

Share Statistics

Avg Vol (3 month) 31.99M
Avg Vol (10 day) 32.76M
Shares Outstanding 5207.51M
Implied Shares Outstanding 6213.48M
Float 8171.09M
% Held by Insiders 17.71%
% Held by Institutions 151.22%
Shares Short (Apr 30, 2024) 414.36M
Short Ratio (Apr 30, 2024) 49.6
Short % of Float (Apr 30, 2024) 46.96%
Short % of Shares Outstanding (Apr 30, 2024) 46.92%
Shares Short (prior month Mar 28, 2024) 411.41M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-9,621.00%

Management Effectiveness

Return on Assets (ttm)-49.47%
Return on Equity (ttm)-167.24%

Income Statement

Revenue (ttm)18.76M
Revenue Per Share (ttm)0.11
Quarterly Revenue Growth (yoy)-99.70%
Gross Profit (ttm)N/A
EBITDA -212.39M
Net Income Avi to Common (ttm)-328.05M
Diluted EPS (ttm)-1.8800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)54.42M
Total Cash Per Share (mrq)0.26
Total Debt (mrq)30.82M
Total Debt/Equity (mrq)54.35%
Current Ratio (mrq)1.71
Book Value Per Share (mrq)0.28

Cash Flow Statement

Operating Cash Flow (ttm)-207.2M
Levered Free Cash Flow (ttm)-120.99M